Risperidone-Induced Neutropenia in a Schizophrenic Patient: A Case Report and Literature Review
Neutropenia is an adverse effect of various pharmacological therapies, including antipsychotics. Among the second-generation antipsychotic (SGA) medications, clozapine is most notable for neutropenic adverse effect. Risperidone, another SGA drug, is linked mainly with metabolic adverse effects, but...
Saved in:
Main Authors: | Ayodele Atolagbe, Stanley Nkemjika, Olusegun Popoola, Oluwatoyin Oladeji, Irina Kogan, Haroon Saeed, Tolulope Olupona |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Psychiatry |
Online Access: | http://dx.doi.org/10.1155/2021/3980872 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concomitant Use of Topiramate Inducing Neutropenia in a Schizophrenic Male Stabilized on Clozapine
by: Pravesh Sharma, et al.
Published: (2016-01-01) -
Serum IL-1β, sIL-2R, IL-6, IL-8 and TNF-α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment
by: Ayşe Binnur Erbağci, et al.
Published: (2001-01-01) -
Neurological Abnormalities in Chinese Schizophrenic Patients
by: Raymond C. K. Chan, et al.
Published: (2007-01-01) -
Unsuccessful Self-Enucleation in a Schizophrenic Patient
by: Noam Bar-Yaakov, et al.
Published: (2014-01-01) -
Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
by: Amilton Dos Santos-Júnior, et al.
Published: (2016-01-01)